Delivery Order SPE2DB22D2006-SPE2DB25FW2UD
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.29 to AmerisourceBergen Drug Corp for the supply of Meloxicam 15 mg tablets in unit dose packaging (100s). This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count), with a ceiling value of $1,838.08 and a firm fixed price structure. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meloxicam 15 mg tablet units (100 count) valued at $1,149.80 on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Meloxicam is a nonsteroidal anti-inflammatory drug commonly used in military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,757.33 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. The contract was competitively awarded without set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of May 7, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 15 mg meloxicam tablets. The contract has a ceiling value of $1,341.52 and a period of performance running through June 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,867,341 units of Meloxicam 15 mg tablets in 180-count bottles, with a ceiling value of $28,109.04. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 6, 2024. This contract is not designated as a set-aside....
- This federal contract award is for the delivery of Meloxicam 15 mg tablets in 180-count bottles. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,774.69, and has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, identified as SPE2DX15D3005|SPE2DX25F3MQX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $17,697.34, is for the delivery of 4,566,307,554 units of Meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through November 4, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2UDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Meloxicam 15 mg tablets in a 90-count package, with a contract value of $2,000.95 and completion targeted for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with DLA demonstrates capability in delivering a wide range of pharmaceutical products, from brand-name and generic medications to specialized medical commodities, across multiple therapeutic areas. This delivery order for Meloxicam, a nonsteroidal anti-inflammatory medication commonly used in military and veteran healthcare settings, exemplifies AmerisourceBergen's role in supporting the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/24/25 |